<DOC>
	<DOCNO>NCT00361894</DOCNO>
	<brief_summary>The purpose study assess 10 mg Bay 59-7939 , take daily tablet , safe prevents blood clot may form knee replacement operation .</brief_summary>
	<brief_title>Regulation Coagulation Orthopedic Surgery Prevent Deep Vein Thrombosis ( DVT ) Pulmonary Embolism ( PE ) . A Study BAY 59-7939 Prevention VTE Subjects Undergoing Elective Total Knee Replacement .</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Male female patient age 18 year Patients schedule elective total knee replacement Active bleeding high risk bleed contraindicate treatment LMWH Contraindication list label condition preclude subject treatment enoxaparin require dose adjustment ( e.g . severe renal impairment , please refer local label enoxaparin country ) Conditions prohibit bilateral venography ( e.g . amputation 1 leg , allergy contrast medium )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>